These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 12817908)

  • 1. A new flow cytometric method for measurement of von Willebrand factor activity.
    Lindahl TL; Fagerberg IH; Larsson A
    Scand J Clin Lab Invest; 2003; 63(3):217-23. PubMed ID: 12817908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly-sensitive plasma von Willebrand factor ristocetin cofactor (VWF:RCo) activity assay by flow cytometry.
    Chen D; Daigh CA; Hendricksen JI; Pruthi RK; Nichols WL; Heit JA; Owen WG
    J Thromb Haemost; 2008 Feb; 6(2):323-30. PubMed ID: 18031294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen.
    Stufano F; Lawrie AS; La Marca S; Berbenni C; Baronciani L; Peyvandi F
    Haemophilia; 2014 Jan; 20(1):147-53. PubMed ID: 24028703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin.
    Graf L; Moffat KA; Carlino SA; Chan AK; Iorio A; Giulivi A; Hayward CP
    Int J Lab Hematol; 2014 Jun; 36(3):341-51. PubMed ID: 24750681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of von Willebrand factor (VWF) activity levels determined by HemosIL AcuStar assay and HemosIL LIA assay with ristocetin cofactor assay by aggregometry.
    Sagheer S; Rodgers S; Yacoub O; Dauer R; Mcrae S; Duncan E
    Haemophilia; 2016 May; 22(3):e200-7. PubMed ID: 27076201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory Testing for von Willebrand Factor Ristocetin Cofactor (VWF:RCo).
    Mohammed S; Favaloro EJ
    Methods Mol Biol; 2017; 1646():435-451. PubMed ID: 28804846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid assay for ristocetin cofactor activity using an automated coagulometer (ACL 9000).
    Lattuada A; Preda L; Sacchi E; Gallo L; Federici AB; Rossi E
    Blood Coagul Fibrinolysis; 2004 Sep; 15(6):505-11. PubMed ID: 15311161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
    Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
    Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method.
    Cabrera N; Moret A; Caunedo P; Cid AR; Vila V; España F; Aznar JA
    Haemophilia; 2013 Nov; 19(6):920-5. PubMed ID: 23730809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential sensitivity of von Willebrand factor (VWF) 'activity' assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen-binding and mAb-based assays.
    Favaloro EJ; Bonar R; Chapman K; Meiring M; Funk Adcock D
    J Thromb Haemost; 2012 Jun; 10(6):1043-54. PubMed ID: 22487084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
    Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
    Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technological advances in diagnostic testing for von Willebrand disease: new approaches and challenges.
    Hayward CP; Moffat KA; Graf L
    Int J Lab Hematol; 2014 Jun; 36(3):334-40. PubMed ID: 24750680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of two new automated assays for measuring von Willebrand activity: HemosIL AcuStar and Innovance.
    de Maistre E; Volot F; Mourey G; Aho LS; Ternisien C; Briquel ME; Bertrand MA; Tardy B; Frotscher B; Nguyen P; Dumont L; Vandroux D; Hézard N; Trossaërt M
    Thromb Haemost; 2014 Oct; 112(4):825-30. PubMed ID: 25103956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an automated platelet-based assay of ristocetin cofactor activity.
    Lawrie AS; Mackie IJ; Machin SJ; Peyvandi F
    Haemophilia; 2011 Mar; 17(2):252-6. PubMed ID: 21070498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an ELISA method for testing VWF ristocetin cofactor activity with improved sensitivity and reliability in the diagnosis of von Willebrand disease.
    Zhao Y; Gu Y; Ji S; Yang J; Yu Z; Ruan C
    Eur J Haematol; 2012 May; 88(5):439-45. PubMed ID: 22268616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
    Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
    Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination.
    Stufano F; Baronciani L; Pagliari MT; Franchi F; Cozzi G; Garcia-Oya I; Bucciarelli P; Boscarino M; Peyvandi F
    J Thromb Haemost; 2015 Oct; 13(10):1806-14. PubMed ID: 26206100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays.
    Favaloro EJ; Mohammed S
    Thromb Res; 2014 Dec; 134(6):1292-300. PubMed ID: 25300811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.